Skip to main content

Table 3 Response to hormonal therapy

From: The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole

Treatment PR (%) SD (%) PD (%) ORR (%) CBR (%) CA125 response (%)
Tamoxifen (n = 43) 6 (14) 22 (51.2) 15 (34.9) 6 (14) 28 (65.1) 10 (23.3)
Letrozole (n = 54) 8 (14.8) 22 (40.7) 24 (44.4) 8 (14.8) 30 (55.6) 12 (22.2)
Total (n = 97) 14 (14.4) 44 (45.4) 39 (40.2) 14 (14.4) 58 (59.8) 22 (22.7)
  1. Abbreviations: CBR clinical benefit rate, ORR objective response rate, PD progressive disease, PR partial response, SD stable disease